Evidence map›Paper›PMID 35499687›Full record

ReviewMolecular biology reports2022

Interplay between PI3K/AKT pathway and heart disorders.

Soudeh Ghafouri-Fard, Ali Khanbabapour Sasi, Bashdar Mahmud Hussen, Hamed Shoorei, Afshan Siddiq, Mohammad Taheri, Seyed Abdulmajid Ayatollahi

Open access · hybridAbstract readReview
In one paragraph

Review in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 2 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 2 syntheses or guidelines pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 4 countries.

Soudeh Ghafouri-FardDepartment of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ali Khanbabapour SasiBiochemistry Group, School of Medicine, Golestan University of Medical Science, Gorgan, Iran.
Bashdar Mahmud HussenDepartment of Pharmacognosy, College of Pharmacy, Hawler Medical University, Kurdistan, Erbil, Iraq.
Hamed ShooreiDepartment of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Afshan SiddiqDepartment of Pharmacology, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan.
Mohammad TaheriInstitute of Human Genetics, Jena University Hospital, Jena, Germany. mohammad.taheri@uni-jena.de.
Seyed Abdulmajid AyatollahiPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. majid_ayatollahi@sbmu.ac.ir.
Shahid Beheshti University of Medical Sciences · IRBirjand University of Medical Sciences · IRGolestan University · IRJena University Hospital · DELebanese French University · IQUniversity of Karachi · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The PI3K/AKT signaling has crucial role in the regulation of numerous physiological functions through activation of downstream effectors and modulation of cell cycle transition, growth and proliferation. This pathway participates in the pathogenesis of several human disorders such as heart diseases through regulation of size and survival of cardiomyocytes, angiogenic processes as well as inflammatory responses. Moreover, PI3K/AKT pathway participates in the process of myocardial injury induced by a number of substances such as H

Indexed as

MercuryMyocardial Reperfusion InjuryApoptosisDoxorubicinEpirubicinHumansHydrogen PeroxideLipopolysaccharidesMyocytes, CardiacPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktDoxorubicinEpirubicinHydrogen PeroxideLipopolysaccharidesMercuryPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktCardiac hypertrophyExpressionHeart diseaseMyocardial infarctionPI3K/AKT pathway

Identifiers

PMID35499687
PMCPMC9515023
OpenAlexW4225291719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.